Michael H. Carrel: 2025 was an exceptional year at AtriCure, Inc. with achievements across our business. This trial is evaluating the benefit of our AtriClip devices on non-AFib patients undergoing ...
A deceptively simple question underlies many global environmental policies: where, exactly, are the world’s forests? A new study suggests the answer depends heavily on which map one consults—and that ...
Mandara Biopharma Inc. announced approval from the FDA to initiate their clinical trials for the treatment of agitation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results